Inactive state |
Monomeric |
Active state |
Oligomeric |
Factor driving oligomerization |
Catenation of by 2–5A bound to ankyrin repeats of multiple monomers |
Titration of HSPA5 bound to luminal domain and catenation of the same from multiple monomers by unfolded proteins |
Activation upon exogenous overexpression |
Yes (demonstrated in vitro for RNaseL) |
Position of ligand–receptor and RNase domain |
N- and C-terminal, respectively |
Ribonuclease domain |
KEN or kinase-extension homology domain |
Role of PK domain in activating RNase |
Nucleotide binding, even in absence of hydrolysis, to conserved residue in protein-kinase like domain is necessary for RNase activity (Tirasophon et al., 1998; Dong and Silverman, 1999; Papa et al., 2003; Lin et al., 2007) |
Nature of RNase substrates |
Both 28S rRNA and mRNAs |
IRE1β can cleave both 28S rRNA and mRNA while IRE1α substrates include only mRNAs (Iwawaki et al., 2001) |
Dissimilarities |
Autophosphorylation |
No |
Yes |
Cleavage substrates |
Beside 28S rRNA, predominantly cleaves mRNAs encoding ribosomal proteins (Andersen et al., 2009) |
Xbp1u and other mRNAs in addition to microRNA precursors which are targeted as part of the RIDD pathway |
Selection of cleavage site |
Cleaved between 2nd and 3rd nucleotide positions of UN/N sites (Han et al., 2014) |
RNA sequence with the consensus of 5′-CUGCAG-3′ in association with a stem-loop (SL) structure essential for recognition of Xbp1u and other mRNAs (Oikawa et al., 2010) |